- Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to
Staphylococcus aureus, 2003–2004 influenza season. Emerg Infect Dis 2006; 12:894–899. - Roberts JC, Gulino SP, Peak KK, et al. Fatal necrotizing pneumonia due to a Panton-Valentine
leukocidin positive community-associated methicillin-sensitiveStaphylococcus aureusand Influenza
co-infection: a case report. Ann Clin Microbiol Antimicrob 2008; 7:5. - Nguyen ET, Kanne JP, Hoang LM, et al. Community-acquired methicillin-resistantStaphylococcus
aureuspneumonia: radiographic and computed tomography findings. J Thorac Imaging 2008;
23:13–19. - Sakaguchi M, Shime N, Fujita N, et al. Current problems in the diagnosis and treatment of hospital-
acquired methicillin-resistantStaphylococcus aureuspneumonia. J Anesth 2008; 22:125–130. - Cunha BA.S. aureusnosocomial pneumonia: clinical aspects. Infect Dis Practice 2007; 31:557–560.
- Vayalumkal JV, Whittingham H, Vanderkooi O, et al. Necrotizing pneumonia and septic shock:
suspecting CA-MRSA in patients presenting to Canadian emergency departments. CJEM 2007;
9:300–303. - Olsen RJ, Burns KM, Chen L, et al. Severe necrotizing fasciitis in a human immunodeficiency
virus-positive patient caused by methicillin-resistantStaphylococcus aureus. J Clin Microbiol 2008;
46:1144–1147. - Young LM, Price CS. Community-acquired methicillin-resistantStaphylococcus aureusemerging as an
important cause of necrotizing fasciitis. Surg Infect 2008; 9:469–474. - Lee TC, Carrick MM, Scott BG, et al. Incidence and clinical characteristics of methicillin-resistant
Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 2007; 194:809–812. - Shurland S, Zhan M, Bradham DD, et al. Comparison of mortality risk associated with bacteremia due
to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.InfectControlHosp
Epidemiol 2007; 28:273–279. - Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated
with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and
methicillin susceptibleStaphylococcus aureus. Clin Infect Dis 2008; 46:799–806. - Haessler S, Mackenzie T, Kirkland KB. Long-term outcomes following with methicillin-resistant or
methicillin-susceptibleStaphylococcus aureus. J Hosp Infect 2008; 69:39–45. - Cunha BA. Newer uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin b,
doxycycline and minocycline revisited. Med Clin North Am 2006; 90:1089–1107. - Cunha BA. Oral antibiotics to treat MRSA infections. J Hosp Infect 2005; 60:88–90.
- Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am 2006;
90:1197–2222. - Martagon-Villami J, Brown RB. IV vs PO antibiotics: who really needs parenteral antibiotics. Antibiot
Clin 2007; 11:429–431. - Kucers A, Crowe SM, Grayson ML, et al. The Use of Antibiotics: A Clinical Review of Antibacterial,
Antifungal and Antiviral Drugs. 5th ed. Oxford: Butterworth-Heinemann, 1997. - Burns CA. Long-term use of daptomycin for MRSA osteomyelitis and joint infection. Scand J Infect
Dis 2008; 40:183–186. - Cunha BA, Krol V, Kodali V. Methicillin-resistantStaphylococcus aureus(MRSA) mitral valve acute
bacterial endocarditis (ABE) in a patient with job’s syndrome (hyperimmunoglobulin E syndrome)
successfully treated with linezolid and high dose daptomycin. Heart Lung 2008; 37:72–75. - Daver NG, Shelburne SA, Atmar RL, et al. Oral step-down therapy is comparable to intravenous
therapy forStaphylococcus aureusosteomyelitis. J Infect 2007; 54:539–544. - Davis SL, McKinnon PS, Hall LM, et al. Daptomycin versus vancomycin for complicated skin and skin
structure infections: clinical and economic outcomes. Pharmacotherapy 2007; 27:1611–1618. - Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin
Microbiol Infect 2008; 14:3–9. - Kohno S, Yamaguchi K, Aikawa N, et al. Linezolid versus vancomycin for the treatment of infections
caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 2007;
60:1361–1369. - Mergenhagen KA, Pasko MT. Daptomycin use after vancomycin -induced neutropenia in a patient
with left-sided endocarditis. Ann Pharmacother 2007; 41:1531–1535. - Mohan S, McDermott BP, Cunha BA. Methicillin-resistantStaphylococcus aureus(MRSA) prosthetic
valve endocarditis (PVE) with paravalvular abscess treated with daptomycin. Heart Lung 2005;
34:69–71. - Moreillon P. New and emerging treatment ofStaphylococcus aureusinfections in the hospital setting.
Clin Microbiol Infect 2008; 14:32–41. - Murthy MH, Olson ME, Wickert RW, et al. Daptomycin non-susceptible methicilin-resistant
Staphylococcus aureusUSA 300 isolate. J Med Microbiol 2008; 57:1036–1038.
510 Cunha